Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012, Article ID 459278, 11 pages
http://dx.doi.org/10.1155/2012/459278
Research Article

Alcohol Activates TGF-Beta but Inhibits BMP Receptor-Mediated Smad Signaling and Smad4 Binding to Hepcidin Promoter in the Liver

Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Nebraska Medical Center, 95820 UNMC, Omaha, NE 68198-5820, USA

Received 28 May 2011; Accepted 7 August 2011

Academic Editor: Angela Dolganiuc

Copyright © 2012 Lisa Nicole Gerjevic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Whitfield, G. Zhu, A. C. Heath, L. W. Powell, and N. G. Martin, “Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers,” Alcoholism: Clinical and Experimental Research, vol. 25, no. 7, pp. 1037–1045, 2001. View at Google Scholar · View at Scopus
  2. M. G. Irving, J. W. Halliday, and L. W. Powell, “Association between alcoholism and increased hepatic iron stores,” Alcoholism: Clinical and Experimental Research, vol. 12, no. 1, pp. 7–13, 1988. View at Google Scholar · View at Scopus
  3. G. N. Ioannou, J. A. Dominitz, N. S. Weiss, P. J. Heagerty, and K. V. Kowdley, “The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia,” Gastroenterology, vol. 126, no. 5, pp. 1293–1301, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. S. Tavill and A. M. Qadri, “Alcohol and iron,” Seminars in Liver Disease, vol. 24, no. 3, pp. 317–325, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Duane, K. B. Raja, R. J. Simpson, and T. J. Peters, “Intestinal iron absorption in chronic alcoholics,” Alcohol and Alcoholism, vol. 27, no. 5, pp. 539–544, 1992. View at Google Scholar · View at Scopus
  6. L. G. Valerio, T. Parks, and D. R. Petersen, “Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury,” Alcoholism: Clinical and Experimental Research, vol. 20, no. 8, pp. 1352–1361, 1996. View at Google Scholar · View at Scopus
  7. M. Lin, R. A. Rippe, O. Niemela, G. Brittenham, and H. Tsukamoto, “Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages,” The American Journal of Physiology, vol. 272, pp. G1355–G1364, 1997. View at Google Scholar
  8. D. D. Harrison-Findik, “Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?” World Journal of Gastroenterology, vol. 15, no. 10, pp. 1186–1193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. D. Harrison-Findik, D. Schafer, E. Klein et al., “Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression,” Journal of Biological Chemistry, vol. 281, no. 32, pp. 22974–22982, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K. R. Bridle, T. K. Cheung, T. L. Murphy et al., “Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease,” Alcoholism: Clinical and Experimental Research, vol. 30, no. 1, pp. 106–112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Ohtake, H. Saito, Y. Hosoki et al., “Hepcidin is down-regulated in alcohol loading,” Alcoholism: Clinical and Experimental Research, vol. 31, no. 1, pp. S2–S8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. D. Harrison-Findik, E. Klein, C. Crist, J. Evans, N. Timchenko, and J. Gollan, “Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol,” Hepatology, vol. 46, no. 6, pp. 1979–1985, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Flanagan, H. Peng, and E. Beutler, “Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations,” Alcoholism: Clinical and Experimental Research, vol. 31, no. 1, pp. 138–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Pigeon, G. Ilyin, B. Courselaud et al., “A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload,” Journal of Biological Chemistry, vol. 276, no. 11, pp. 7811–7819, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. C. H. Park, E. V. Valore, A. J. Waring, and T. Ganz, “Hepcidin, a urinary antimicrobial peptide synthesized in the liver,” Journal of Biological Chemistry, vol. 276, no. 11, pp. 7806–7810, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Nicolas, L. Viatte, M. Bennoun, C. Beaumont, A. Kahn, and S. Vaulont, “Hepcidin, a new iron regulatory peptide,” Blood Cells, Molecules & Diseases, vol. 29, no. 3, pp. 327–335, 2002. View at Google Scholar · View at Scopus
  17. E. Nemeth, M. S. Tuttle, J. Powelson et al., “Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization,” Science, vol. 306, no. 5704, pp. 2090–2093, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. D. M. Kingsley, “The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms,” Genes and Development, vol. 8, no. 2, pp. 133–146, 1994. View at Google Scholar · View at Scopus
  19. L. Lin, E. V. Valore, E. Nemeth, J. B. Goodnough, V. Gabayan, and T. Ganz, “Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4,” Blood, vol. 110, no. 6, pp. 2182–2189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Truksa, H. Peng, P. Lee, and E. Beutler, “Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10289–10293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Babitt, F. W. Huang, Y. Xia, Y. Sidis, N. C. Andrews, and H. Y. Lin, “Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance,” Journal of Clinical Investigation, vol. 117, no. 7, pp. 1933–1939, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. L. Babitt, F. W. Huang, D. M. Wrighting et al., “Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression,” Nature Genetics, vol. 38, no. 5, pp. 531–539, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Andriopoulos, E. Corradini Jr., Y. Xia et al., “BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism,” Nature Genetics, vol. 41, no. 4, pp. 482–487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Meynard, L. Kautz, V. Darnaud, F. Canonne-Hergaux, H. Coppin, and M. P. Roth, “Lack of the bone morphogenetic protein BMP6 induces massive iron overload,” Nature Genetics, vol. 41, no. 4, pp. 478–481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Kautz, D. Meynard, A. Monnier et al., “Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver,” Blood, vol. 112, no. 4, pp. 1503–1509, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Arndt, U. Maegdefrau, C. Dorn, K. Schardt, C. Hellerbrand, and A. K. Bosserhoff, “Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo,” Gastroenterology, vol. 138, no. 1, pp. 372–382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Kautz, C. Besson-Fournier, D. Meynard, C. Latour, and M. P. Roth, “Iron overload induces BMP6 expression in the liver but not in the duodenum,” Haematologica, vol. 96, pp. 199–203, 2011. View at Google Scholar
  28. D. Chen, M. Zhao, and G. R. Mundy, “Bone morphogenetic proteins,” Growth Factors, vol. 22, no. 4, pp. 233–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Massague, J. Seoane, and D. Wotton, “Smad transcription factors,” Genes and Development, vol. 19, no. 23, pp. 2783–2810, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Piek, C. H. Heldin, and P. T. Dijke, “Specificity, diversity, and regulation in TGF-β superfamily signaling,” FASEB Journal, vol. 13, no. 15, pp. 2105–2124, 1999. View at Google Scholar · View at Scopus
  31. C. H. Heldin, K. Miyazono, and P. Ten Dijke, “TGF-β signalling from cell membrane to nucleus through SMAD proteins,” Nature, vol. 390, no. 6659, pp. 465–471, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. R. H. Wang, C. Li, X. Xu et al., “A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression,” Cell Metabolism, vol. 2, no. 6, pp. 399–409, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. V. Siegmund, S. Dooley, and D. A. Brenner, “Molecular mechanisms of alcohol-induced hepatic fibrosis,” Digestive Diseases, vol. 23, no. 3-4, pp. 264–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Meyer, N. M. Meindl-Beinker, and S. Dooley, “TGF-beta signaling in alcohol induced hepatic injury,” Frontiers in Bioscience, vol. 15, pp. 740–749, 2010. View at Google Scholar
  35. P. Coyle, J. C. Philcox, and A. M. Rofe, “Metallothionein-null mice absorb less Zn from an egg-white diet, but a similar amount from solutions, although with altered intertissue Zn distribution,” Journal of Nutrition, vol. 129, no. 2, pp. 372–379, 1999. View at Google Scholar · View at Scopus
  36. D. D. Harrison-Findik, E. Klein, J. Evans, and J. Gollan, “Regulation of liver hepcidin expression by alcohol in vivo does not involve Kupffer cell activation or TNF-{alpha} signaling,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 296, pp. G112–G118, 2009. View at Google Scholar
  37. A. S. Weinmann, S. M. Bartley, T. Zhang, M. Q. Zhang, and P. J. Farnham, “Use of chromatin immunoprecipitation to clone novel E2F target promoters,” Molecular and Cellular Biology, vol. 21, no. 20, pp. 6820–6832, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Breitkopf, S. Haas, E. Wiercinska, M. V. Singer, and S. Dooley, “Anti-TGF-β strategies for the treatment of chronic liver disease,” Alcoholism: Clinical and Experimental Research, vol. 29, no. 11, pp. 121S–131S, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. D. D. Harrison-Findik, “Role of alcohol in the regulation of iron metabolism,” World Journal of Gastroenterology, vol. 13, no. 37, pp. 4925–4930, 2007. View at Google Scholar · View at Scopus
  40. T. B. Chaston, P. Matak, K. Pourvali, S. K. Srai, A. T. McKie, and P. A. Sharp, “Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling,” American Journal of Physiology—Cell Physiology, vol. 300, no. 4, pp. C888–C895, 2011. View at Publisher · View at Google Scholar
  41. X. Wu, M. S. Chang, S. A. Mitsialis, and S. Kourembanas, “Hypoxia regulates bone morphogenetic protein signaling through C-terminal-binding protein 1,” Circulation Research, vol. 99, no. 3, pp. 240–247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. W. French, N. C. Benson, and P. S. Sun, “Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats,” Hepatology, vol. 4, no. 5, pp. 912–917, 1984. View at Google Scholar · View at Scopus
  43. N. Dumont and C. L. Arteaga, “A kinase-inactive type II TGFbeta receptor impairs BMP signaling in human breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 301, pp. 108–112, 2003. View at Google Scholar
  44. J. D. Yan, S. Yang, J. Zhang, and T. H. Zhu, “BMP6 reverses TGF-β1-induced changes in HK-2 cells: implications for the treatment of renal fibrosis,” Acta Pharmacologica Sinica, vol. 30, no. 7, pp. 994–1000, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. A. I. Cederbaum, “Role of lipid peroxidation and oxidative stress in alcohol toxicity,” Free Radical Biology and Medicine, vol. 7, no. 5, pp. 537–539, 1989. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Tsukamoto, Y. Takei, C. J. McClain et al., “How is the liver primed or sensitized for alcoholic liver disease?” Alcoholism: Clinical and Experimental Research, vol. 25, no. 5, pp. 171S–181S, 2001. View at Google Scholar · View at Scopus
  47. S. Wang and R. Hirschberg, “BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells,” The American Journal of Physiology, vol. 284, no. 5, pp. F1006–F1013, 2003. View at Google Scholar · View at Scopus
  48. G. M. Mitu, S. Wang, and R. Hirschberg, “BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury,” The American Journal of Physiology—Renal Physiology, vol. 293, no. 5, pp. F1641–F1648, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Fransvea, U. Angelotti, S. Antonaci, and G. Giannelli, “Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells,” Hepatology, vol. 47, no. 5, pp. 1557–1566, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Yang, J. Du, Z. Wang et al., “BMP-6 promotes E-cadherin expression through repressing δEF1 in breast cancer cells,” BMC Cancer, vol. 7, article 211, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Tsukamoto, W. Horne, S. Kamimura et al., “Experimental liver cirrhosis induced by alcohol and iron,” Journal of Clinical Investigation, vol. 96, no. 1, pp. 620–630, 1995. View at Google Scholar · View at Scopus
  52. A. I. Cederbaum, “Iron and CYP2E1-dependent oxidative stress and toxicity,” Alcohol, vol. 30, no. 2, pp. 115–120, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. L. M. Fletcher and L. W. Powell, “Hemochromatosis and alcoholic liver disease,” Alcohol, vol. 30, no. 2, pp. 131–136, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Corradini, C. Garuti, G. Montosi et al., “Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis,” Gastroenterology, vol. 137, no. 4, pp. 1489–1497, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Kautz, D. Meynard, C. Besson-Fournier et al., “BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression,” Blood, vol. 114, no. 12, pp. 2515–2520, 2009. View at Publisher · View at Google Scholar · View at Scopus